• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

More understanding needed on dexamethasone: WHO

By PTI
|

London, June 17: The emergencies chief of the World Health Organisation welcomed the news this week that dexamethasone, a cheap steroid, was shown in a British trial to reduce deaths among patients critically ill with the coronavirus, but said it was too soon to change how patients are treated.

Representational Image

“It's one of the breakthroughs we're going to need to effectively deal with COVID-19, but it's still preliminary data,” said Dr. Michael Ryan at a press briefing on Wednesday.

“We will pull together the necessary expert group... and come to a decision around our clinical advice to countries.” Ryan said that “this is not the time to rush to change clinical practice” and that it was crucial to understand issues like what dose should be used on patients, how patients would be assessed and if there were adequate supplies of the drug.

    S Jaishankar tells Chinese counterpart: Chinese side took pre-meditated action | Oneindia News

    What is Dexamethasone and how it is effective in treating COVID-19

    On Tuesday, when the British researchers announced their findings, the department of health said the dexamethasone had been approved to treat all hospitalized COVID-19 patients, effectively immediately.

    WHO director-general Tedros Adhanom Ghebreyesus noted that in the last two months, more than 6 million coronavirus cases have been logged and said cases were still accelerating globally. In the first two months, only 85,000 cases were reported, mostly from China.

    For Daily Alerts
    Get Instant News Updates
    Enable
    x
    Notification Settings X
    Time Settings
    Done
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X
    X
    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more